Trial NCT03681951

View at ClinicalTrials.gov 
Org. Study IDs: 205013

Last trial update was posted on 2020-07-31

MeSH Interventions

Pembrolizumab

MeSH Conditions

Pancreatic Neoplasms

Other Conditions

Neoplasms, Pancreatic

Stopping Reasons

The study was terminated following an internal review of the company's current research and development portfolio.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID